PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pantoprazole Sodium In 0.9% Sodium Chloride, and what generic alternatives are available?
Pantoprazole Sodium In 0.9% Sodium Chloride is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.
The generic ingredient in PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pantoprazole Sodium In 0.9% Sodium Chloride
A generic version of PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE was approved as pantoprazole sodium by DR REDDYS LABS LTD on January 19th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE?
- What are the global sales for PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE?
- What is Average Wholesale Price for PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE?
Summary for PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 23 |
| DailyMed Link: | PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE at DailyMed |
Recent Clinical Trials for PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alexandria University | Phase 3 |
| Mansoura University | Phase 1/Phase 2 |
| Federal University of São Paulo | Phase 4 |
See all PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE clinical trials
Pharmacology for PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE
| Drug Class | Proton Pump Inhibitor |
| Mechanism of Action | Proton Pump Inhibitors |
US Patents and Regulatory Information for PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | pantoprazole sodium | SOLUTION;INTRAVENOUS | 217512-001 | Feb 14, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Baxter Hlthcare Corp | PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | pantoprazole sodium | SOLUTION;INTRAVENOUS | 217512-002 | Feb 14, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Baxter Hlthcare Corp | PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | pantoprazole sodium | SOLUTION;INTRAVENOUS | 217512-003 | Feb 14, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
